Background
The higher clinical complexity that features older adults is well represented by the concept of frailty, a condition characterized by increased vulnerability to stressors and reduced homeostatic reserves [
1]. Physical decline is considered the cardinal sign of frailty [
2,
3]; indeed, aging is typically characterized by muscle wasting that progressively causes disability, loss of muscle function and of self-sufficiency in older adults. This phenomenon is called sarcopenia, a term that describes the age-related loss of muscle mass and muscle strength and/or function (i.e., dynapenia) [
4‐
8]. The etiology of sarcopenia is multifactorial, involving many biological mechanisms [
9,
10], like neuromuscular junction dysfunction, reduced satellite cell number/function, intramuscular adipose tissue infiltration [
11] as well as chronic inflammation [
12]. It has been proposed that sarcopenia may be the biological substrate for the development of physical frailty [
13,
14]. However, the causal relationship between the two manifestations remains largely unknown.
Several proteins and biomolecules involved in inflammation and in oxidative stress are hypothesized to play a pathogenetic role in frailty and sarcopenia [
15]. Among these biomolecules, microRNAs (miRNAs) are involved in various pathways and cellular mechanisms that are potentially associated with sarcopenia, including satellite cell regulation [
16,
17] and the functionality of muscle fibers and mitochondria [
18]. Notably, miRNAs have also repeatedly been associated with chronic conditions in which sarcopenia is more frequently observed, such as neurodegenerative pathologies [reviewed by
19].
miRNAs are short single-stranded RNA molecules (about 22 nucleotides) that are usually coded within introns. miRNAs recognize complementary patterns mainly in the 3′ untranslated region (3′-UTR) of target mRNAs and regulate their expression by degradation or translation blockage, acting as critical post-transcriptional mediators of cell function [
20‐
22]. miRNAs also play a crucial role in diseases, as their ability to regulate the expression of specific genes results in the control and modulation of the activity of multiple biological pathways [reviewed by
22].
We have recently shown that serum miR-451a concentration is significantly increased in severe sarcopenia; we also observed that serum concentration of this miRNA, as well as that of miR-93-5p, miR-155-5p, miR-421-3p, miR-425-5p, miR-495-3p and miR-744-5p, is modulated by rehabilitation in severe sarcopenic patients [
23]. On the basis of that finding, we analyzed whether these miRNAs are deregulated in frail subjects as well in comparison with robust subjects, and verified if an intervention program based on a multicomponent exercise protocol could modulate their expression.
Discussion
In the present work we analyzed the serum miRNA concentration in frail and robust subjects who underwent a multicomponent exercise program; results showed that: (1) miR-451a is more expressed in frail compared to robust subjects; and (2) the multicomponent exercise program results on a differential effect on miRNAs expression, as it increased miR-155-5p and reduced miR-93-5p and miR-495-3p.
The age-related decline of muscle activity (loss of mass and strength) is an overlapping aspect between sarcopenia (a complex disease in which several factors—genetics, environmental, inflammation, hormones, neuromuscular degeneration) and frailty, a state of increased vulnerability to stress due decreased physiological reserve in multiple functions [
35,
36]. Because in western countries life expectancy constantly increases, age-related diseases, are a major concern for public health. For this reason, the definition of biomolecules that could be used as biomarkers of physical frailty and/or possible risk of developing sarcopenia, would be extremely important.
In our previous work, serum concentration of miR-451a was found to be significantly increased in severe sarcopenic patients compared to robust subjects, suggesting this miRNA as a possible biomarker of the disease [
23]. In the present work we found that serum concentration of this same miRNA is increased as well in physical frail subjects: individuals with a SPPB score lower than robust subjects but not (yet) suffering from sarcopenia.
miR-451a is coded by a gene localized at chromosome 17 (17q11.2) [
37], is mainly expressed in skeletal muscle, and is known to play a key role in several human tumors [
38‐
41]. Interestingly, miR-451a expression was observed to be increased in muscles of powerlifter [
42] and of people that are low-responders to resistance exercise training [
43]. miR-451a concentration in skeletal muscle was also shown to be inversely correlated to age in rhesus macaques [
44], whereas its plasma concentration was inversely correlated with whole body muscle mass in middle aged men [
42]. Notably, both findings indicate a possible role played by this miRNA in the age-associated decline of muscle mass and function characteristic of frailty and sarcopenia. miR-451a is also present in serum, where it can be found either inside vesicles or as non-vesicle associated protein (miRNA-protein, or miRNA-lipid/lipoprotein complexes) [
40,
45‐
48]. Importantly, when inside vesicles miR-451a miRNA regulates innate immune response, as it was shown to suppress the production of pro-inflammatory cytokines after influenza vaccine [
45] and, at least in vitro, even in the course of influenza A infection [
49]. To the best of our knowledge, though, the only results suggesting an involvement of miR-451a in sarcopenia are the ones we have recently published [
23], and no data are available on the possible relationship between this miRNA and frailty. Results herein indicating that plasma concentration of miR-451a is significantly increased in physical frailty suggests that this miRNA is a precocious and sensible biomarker of age-related muscle alterations that can be analyzed in easy-to-collect samples obtained with a standard venipuncture.
miR-425-3p and miR-93-5p were more expressed in serum of frail subjects as well, although without reaching statistical significance. To note, in these individuals the concentration of miR-93-5p negatively correlated with SPPB score. Thus, miR-93-5p serum concentration in physical frail subjects is very similar to that of robust individuals, and its concentration increases with the worsening of the impairment. Alteration in serum concentration of miR-425-3p (3p21.31) and miR-93-5p (7q22.1) were observed to be associated with multiple human tumors [
50‐
53]. The mouse mmu-miR-425-3p was also found to be expressed in animal muscle tissue and to be a possible biomarker for viral myocarditis, suggesting a role for this miRNA in muscle-related pathologies. Plasma concentration of miR-93-5p, on the other hand, was recently shown to be reduced in sarcopenic patients [
54]. These data are in apparent contrast with ours; this apparent discrepancy can be explained as follows: (1) we studied physical frail individuals whereas He analyzed sarcopenic patients; and (2) we analyzed miR-93-5p serum concentration by ddPCR, which quantifies in an absolute way (copies/ng) miRNA concentration, whereas He measured miR-93-5p in plasma using traditional qPCR, a method in which miRNA concentration is relative to a synthetic reference miRNA. Notably, miR-93-5p was shown to be augmented also in serum, bone tissue and bone cells of patients suffering from osteoporosis, in whom miR-93-5p concentration was correlated with bone mass density [
55]. Nevertheless, studies in larger groups, analyzing miRNAs expression in serum and in plasma, and possibly including different ethnicity, are necessary to clarify this discrepancy.
All the individuals enrolled in the study underwent an intervention program based on physical activity at home. Importantly, this activity has an important positive and beneficial effects in both groups, with a significant improvement of physical condition as measured by SPPB and handgrip, in particular for frail subjects, in accordance with previous papers [reviewed by
56], indicating that this multicomponent program is a useful strategy to improve physical performance, at least in frailty.
Physical activity modulated serum expression of miR-93-5p, miR-495-3p and miR-155-5p both in frail and robust subjects. In particular: miR-495-3p and miR-93-5p were robustly down-regulated whereas miR-155-5p was up-regulated by intervention in in both groups. A very limited amount of data is available on the effect of program of intervention on circulatory miRNAs expression, and these data usually stem from analyses performed in athletes or in young people [i.e.
57,
58]. Scarce results are available on the effect of acute or intense exercise on circulatory miRNAs expression in older adults (i.e.
57,
59]. We have recently shown that rehabilitation has an effect on the expression of miRNAs that are related to SNAP-25 and IL-17 expression in severe sarcopenic patients [
23,
60]. To the best of our knowledge, these are the first results showing the intervention has a significant effect on the expression of miRNA detectable in serum and possibly involved in muscle metabolism in physical frail subjects. Notably, results herein suggest that miRNAs expression is modulated by physical activity in older adults. As these proteins target several biological processes, modulation of their expression might regulate diverse mechanisms that contribute to the pathophysiology of the frailty. Although the multicomponent exercise program was similar for frail and robust subjects, and although the demographic variables were comparable between the two groups, we cannot exclude that other factors, including drugs, diet, comorbidities, etc., could have influenced the miRNAs expression.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.